Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -154.06% is 19% above its 5-year average of -190.74%, around the middle of its 5-year range (-468.56%–12.76%).
As of the fiscal period ended Thursday, April 30, 2026. 22.42% above its 12-month average of -198.59%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-04-30): -154.06%.
RETURN ON EQUITY (ROE)
-154.06%
RETURN ON EQUITY (ROE) AVG TTM
-198.59%
RETURN ON EQUITY (ROE) AVG 3Y
-272.18%
RETURN ON EQUITY (ROE) AVG 5Y
-190.74%
RETURN ON EQUITY (ROE) AVG 10Y
-235.32%
RETURN ON EQUITY (ROE) AVG 15Y
-192.31%
RETURN ON EQUITY (ROE) AVG 20Y
-114.20%
CURRENT VS TTM AVG
+22.42%
CURRENT VS 3Y AVG
+43.40%
CURRENT VS 5Y AVG
+19.23%
CURRENT VS 10Y AVG
+34.53%
CURRENT VS 15Y AVG
+19.89%
CURRENT VS 20Y AVG
-34.90%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-266.72%
vs the sector median at left
BriaCell Therapeutics Corp.
Market Cap
$34.97M
Return on Equity (ROE)
-154.06%
TTM Avg
-198.59%
3Y Avg
-272.18%
5Y Avg
-190.74%
Market Cap
$35.76M
Return on Equity (ROE)
-161.63%
TTM Avg
-60.21%
3Y Avg
-26.37%
5Y Avg
-20.13%
Market Cap
$35.39M
Return on Equity (ROE)
-819.34%
TTM Avg
-116.46%
3Y Avg
-74.90%
5Y Avg
-96.78%
Market Cap
$35.84M
Return on Equity (ROE)
-476.77%
TTM Avg
-979.99%
3Y Avg
-646.46%
5Y Avg
-421.61%
Market Cap
$34.23M
Return on Equity (ROE)
329.02%
TTM Avg
154.76%
3Y Avg
265.18%
5Y Avg
128.71%
Market Cap
$35.84M
Return on Equity (ROE)
-160.05%
TTM Avg
-184.57%
3Y Avg
-168.71%
5Y Avg
-141.15%
Market Cap
$36.15M
Return on Equity (ROE)
14.51%
TTM Avg
6.28%
3Y Avg
-34.57%
5Y Avg
-35.24%
Market Cap
$33.61M
Return on Equity (ROE)
-44.50%
TTM Avg
-16.33%
3Y Avg
-36.34%
5Y Avg
-33.52%
Market Cap
$33.29M
Return on Equity (ROE)
N/A
TTM Avg
105.22%
3Y Avg
53.02%
5Y Avg
47.52%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | $34.97M | -154.06% | -198.59% | -272.18% | -190.74% |
| DocGo Inc. (DCGO)vs › | $35.76M | -161.63% | -60.21% | -26.37% | -20.13% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.39M | -819.34% | -116.46% | -74.90% | -96.78% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -476.77% | -979.99% | -646.46% | -421.61% |
| Elutia Inc (ELUT)vs › | $34.23M | 329.02% | 154.76% | 265.18% | 128.71% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | -160.05% | -184.57% | -168.71% | -141.15% |
| Nephros, Inc. (NEPH)vs › | $36.15M | 14.51% | 6.28% | -34.57% | -35.24% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | -44.50% | -16.33% | -36.34% | -33.52% |
| Scilex Holding Company (SCLX)vs › | $33.29M | N/A | 105.22% | 53.02% | 47.52% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | -238.24% | 203.84% | 55.01% | 16.87% |
ROE
-154.1%
ROA
-136.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-04-30 | -154.06% |
| 2026-01-31 | -124.86% |
| 2025-10-31 | -403.73% |
| 2025-07-31 | -149.98% |
| 2025-04-30 | -160.32% |
| 2025-01-31 | -314.31% |
| 2024-10-31 | -401.60% |
| 2023-10-31 | -468.56% |
| 2022-10-31 | -145.29% |
| 2022-07-31 | -399.47% |
| 2022-04-30 | -61.43% |
| 2022-01-31 | -34.45% |
| 2021-10-31 | -51.44% |
| 2021-07-31 | -4.35% |
| 2021-04-30 | 12.76% |
| 2019-04-30 | -750.81% |
| 2018-07-31 | -450.02% |
| 2018-04-30 | -158.90% |
| 2018-01-31 | -664.14% |
| 2017-10-31 | -279.03% |
| 2017-07-31 | -331.87% |
| 2017-04-30 | -112.56% |
| 2017-01-31 | -90.13% |
| 2016-10-31 | -100.55% |
| 2016-07-31 | -199.20% |
| 2016-04-30 | -119.95% |
| 2016-01-31 | -303.59% |
| 2015-10-31 | -333.04% |
| 2015-07-31 | -229.96% |
| 2015-04-30 | -681.85% |
| 2015-01-31 | -687.35% |
| 2014-04-30 | -10.87% |
| 2014-01-31 | -5.52% |
| 2013-10-31 | -4.98% |
| 2013-07-31 | -4.04% |
| 2013-04-30 | -8.03% |
| 2013-01-31 | -10.52% |
| 2012-10-31 | -9.45% |
| 2012-07-31 | -9.97% |
| 2012-04-30 | -9.75% |
| 2012-01-31 | -8.56% |
| 2011-10-31 | -10.23% |
| 2011-07-31 | -9.00% |
| 2011-04-30 | -6.63% |
| 2011-01-31 | -86.05% |
| 2010-10-31 | -67.86% |
| 2010-07-31 | -61.93% |
| 2010-04-30 | -38.13% |
| 2010-01-31 | -28.63% |
| 2009-10-31 | -25.41% |
| 2009-07-31 | -22.29% |
| 2009-04-30 | -33.92% |
| 2009-01-31 | -78.96% |
| 2008-10-31 | -61.17% |
| 2008-07-31 | -27.48% |
| 2008-04-30 | -18.52% |
| 2008-01-31 | -13.81% |
| 2007-10-31 | -15.23% |
| 2007-07-31 | -24.15% |
